Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Case report

Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report

Authors: Chandrika Jayakanthi Subasinghe, Nirmala Dushyanthi Sirisena, Chula Herath, Knut Erik Berge, Trond Paul Leren, Uditha Bulugahapitiya, Vajira Harshadeva Weerabaddana Dissanayake

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Gitelman syndrome (GS) is a rare autosomal recessively inherited salt-wasting tubulopathy associated with mutations in the SLC12A3 gene, which encodes for NaCl cotransporter (NCC) in the kidney.

Case presentation

In this report, we describe two siblings from a Sri Lankan non-consanguineous family presenting with hypokalaemia associated with renal potassium wasting, hypomagnesemia, hypocalciuria and hypereninemic hyperaldosteronism with normal blood pressure. Genetic testing showed that both were homozygotes for a novel missense mutation in exon 10 of the SLC12A3 gene [NM_000339.2, c.1276A > T; p.N426Y], which has not previously been reported in the literature in association with GS. Their mother was a heterozygous carrier for the same mutation. The father was not alive at the time of testing. This novel mutation extends the spectrum of known SLC12A3 gene mutations and further supports the allelic heterogeneity of GS. Interestingly both siblings had young onset Diabetes with strong family history.

Conclusion

These findings have implications in providing appropriate genetic counseling to the family with regard to the risk associated with inbreeding, the detection of carrier/presymptomatic relatives. It further expands the known spectrum of genotypic and phenotypic characteristics of Gitelman syndrome.
Literature
1.
go back to reference Gitelman HJ, Graham JB, Welt GL. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:211–35. Gitelman HJ, Graham JB, Welt GL. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:211–35.
2.
go back to reference Bettinelli A, Bianchelli A, Girardin E, Caringella A, Cecconi M, Appiani AC, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120:38–43.CrossRefPubMed Bettinelli A, Bianchelli A, Girardin E, Caringella A, Cecconi M, Appiani AC, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120:38–43.CrossRefPubMed
3.
go back to reference Bichet DG, Fujiwara TM. Reabsorption of sodium chloride: lessons from the chloride channels. N Engl J Med. 2004;350:1281–3.CrossRefPubMed Bichet DG, Fujiwara TM. Reabsorption of sodium chloride: lessons from the chloride channels. N Engl J Med. 2004;350:1281–3.CrossRefPubMed
4.
go back to reference Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HM. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res. 2002;48:754–8.CrossRef Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HM. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res. 2002;48:754–8.CrossRef
5.
go back to reference Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Mounoz E, Debaix H, et al. Spectrum of Mutations in Gitelman Syndrome. J Am Soc Nephrol. 2011;22:693–703.CrossRefPubMedPubMedCentral Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Mounoz E, Debaix H, et al. Spectrum of Mutations in Gitelman Syndrome. J Am Soc Nephrol. 2011;22:693–703.CrossRefPubMedPubMedCentral
6.
go back to reference Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24–30.CrossRefPubMed Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24–30.CrossRefPubMed
7.
go back to reference Lee JW, Lee J, Heo NJ, Cheong H, Han JS. Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like Syndrome. J Korean Med Sci. 2016;31:47–54.CrossRefPubMed Lee JW, Lee J, Heo NJ, Cheong H, Han JS. Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like Syndrome. J Korean Med Sci. 2016;31:47–54.CrossRefPubMed
8.
go back to reference Ren H, Qin L, Wang W, Ma J, Zhang W, Shen PY, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome. Am J Nephrol. 2013;37:152–7.CrossRefPubMed Ren H, Qin L, Wang W, Ma J, Zhang W, Shen PY, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome. Am J Nephrol. 2013;37:152–7.CrossRefPubMed
9.
go back to reference Biagioni M, Marigliano M, Iannilli A, Cester A, Gatti S, D’Alba I, et al. Diabetic Ketoacidosis Complicated With Previously Unknown Gitelman Syndrome in a Tunisian Child. Diabetes Care. 2011;34, e107.CrossRefPubMedPubMedCentral Biagioni M, Marigliano M, Iannilli A, Cester A, Gatti S, D’Alba I, et al. Diabetic Ketoacidosis Complicated With Previously Unknown Gitelman Syndrome in a Tunisian Child. Diabetes Care. 2011;34, e107.CrossRefPubMedPubMedCentral
10.
go back to reference Zangeneh F, Chiang M, Zangenech F. Pitfalls in the Laboratory Diagnosis of Diabetic Ketoacidosis in Gitelman’s Syndrome. Diabetes Care. 2003;26:955.CrossRefPubMed Zangeneh F, Chiang M, Zangenech F. Pitfalls in the Laboratory Diagnosis of Diabetic Ketoacidosis in Gitelman’s Syndrome. Diabetes Care. 2003;26:955.CrossRefPubMed
11.
go back to reference Lin S, Shiang J, Huang C, Yang S, Hsu Y, Cheng C. Phenotype and Genotype Analysis in Chinese Patients with Gitelman Syndrome. J Clin Endocrinol Metab. 2005;90:2500–7.CrossRefPubMed Lin S, Shiang J, Huang C, Yang S, Hsu Y, Cheng C. Phenotype and Genotype Analysis in Chinese Patients with Gitelman Syndrome. J Clin Endocrinol Metab. 2005;90:2500–7.CrossRefPubMed
12.
go back to reference Munoz EV, Chang Q, Bindels RJ, Devuyst O. Gitelman syndrome: towards genotype-phenotype correlations? Pediatr Nephrol. 2007;22:326–32.CrossRef Munoz EV, Chang Q, Bindels RJ, Devuyst O. Gitelman syndrome: towards genotype-phenotype correlations? Pediatr Nephrol. 2007;22:326–32.CrossRef
13.
go back to reference Fedeli GGC, Cosmai ML, Badalamenti S, Ponticelli C. Gitelman syndrome: pathophysiological and clinical aspects. Q J Med. 2010;103:741–8.CrossRef Fedeli GGC, Cosmai ML, Badalamenti S, Ponticelli C. Gitelman syndrome: pathophysiological and clinical aspects. Q J Med. 2010;103:741–8.CrossRef
14.
go back to reference Pham PCT, Pham PMT, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in patients with type 2 DM. Clin J Am Soc Nephrol. 2007;2:366–73.CrossRefPubMed Pham PCT, Pham PMT, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in patients with type 2 DM. Clin J Am Soc Nephrol. 2007;2:366–73.CrossRefPubMed
15.
go back to reference Dronavalli S, Bakris GL. Mechanistic insights into diuretic-induced insulin resistance. Hypertension. 2008;52:1009–11.CrossRefPubMed Dronavalli S, Bakris GL. Mechanistic insights into diuretic-induced insulin resistance. Hypertension. 2008;52:1009–11.CrossRefPubMed
16.
go back to reference Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte Nuclear Factor 1β - Associated Kidney Disease: More than renal cyst and Diabetes. J Am Soc Nephrol. 2016;27:345–53.CrossRefPubMed Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte Nuclear Factor 1β - Associated Kidney Disease: More than renal cyst and Diabetes. J Am Soc Nephrol. 2016;27:345–53.CrossRefPubMed
Metadata
Title
Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report
Authors
Chandrika Jayakanthi Subasinghe
Nirmala Dushyanthi Sirisena
Chula Herath
Knut Erik Berge
Trond Paul Leren
Uditha Bulugahapitiya
Vajira Harshadeva Weerabaddana Dissanayake
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0563-0

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.